Table 1.
Primary | Metastatic | |||
---|---|---|---|---|
Assigned Dose (Gy) | Predicted %risk of RILD without amifostine10 | Predicted %Risk of RILD with Amifostine | Predicted %risk of RILD without amifostine10 | Predicted %Risk of RILD with Amifostine |
32 | 2.6 | <0.1 | · | · |
34 | 7.6 | 0.1 | · | · |
36 | 17.6 | 0.3 | 2.3 | <0.1 |
38 | 33.4 | 1.0 | 6.0 | <0.1 |
40 | 53.0 | 2.6 | 13.3 | 0.2 |
42 | 71.9 | 6.2 | 25.2 | 0.6 |
44 | 86.1 | 12.9 | 41.2 | 1.5 |
46 | 94.4 | 23.3 | 58.8 | 3.4 |
48 | · | · | 74.8 | 7.1 |
50 | · | · | 86.7 | 13.3 |
52 | · | · | 94.0 | 22.5 |